nodes	percent_of_prediction	percent_of_DWPC	metapath
Lansoprazole—CYP1A1—chronic obstructive pulmonary disease	0.213	0.509	CbGaD
Lansoprazole—CYP1A2—chronic obstructive pulmonary disease	0.205	0.491	CbGaD
Lansoprazole—CYP2C19—Arformoterol—chronic obstructive pulmonary disease	0.0291	0.0865	CbGbCtD
Lansoprazole—CYP2C19—Formoterol—chronic obstructive pulmonary disease	0.0291	0.0865	CbGbCtD
Lansoprazole—CYP2C8—Montelukast—chronic obstructive pulmonary disease	0.0262	0.0781	CbGbCtD
Lansoprazole—CYP2C9—Formoterol—chronic obstructive pulmonary disease	0.0242	0.0719	CbGbCtD
Lansoprazole—CYP2C9—Arformoterol—chronic obstructive pulmonary disease	0.0242	0.0719	CbGbCtD
Lansoprazole—CYP1A2—Aminophylline—chronic obstructive pulmonary disease	0.0228	0.0679	CbGbCtD
Lansoprazole—CYP2D6—Arformoterol—chronic obstructive pulmonary disease	0.0221	0.0658	CbGbCtD
Lansoprazole—CYP2D6—Formoterol—chronic obstructive pulmonary disease	0.0221	0.0658	CbGbCtD
Lansoprazole—CYP2D6—Tiotropium—chronic obstructive pulmonary disease	0.0197	0.0586	CbGbCtD
Lansoprazole—CYP3A4—Salbutamol—chronic obstructive pulmonary disease	0.0185	0.0552	CbGbCtD
Lansoprazole—CYP2C9—Montelukast—chronic obstructive pulmonary disease	0.0183	0.0545	CbGbCtD
Lansoprazole—CYP3A4—Tiotropium—chronic obstructive pulmonary disease	0.0125	0.0373	CbGbCtD
Lansoprazole—CYP2C19—Prednisone—chronic obstructive pulmonary disease	0.0122	0.0363	CbGbCtD
Lansoprazole—CYP3A4—Aminophylline—chronic obstructive pulmonary disease	0.0119	0.0356	CbGbCtD
Lansoprazole—CYP3A4—Montelukast—chronic obstructive pulmonary disease	0.0106	0.0317	CbGbCtD
Lansoprazole—ABCB1—Prednisolone—chronic obstructive pulmonary disease	0.0104	0.031	CbGbCtD
Lansoprazole—ABCB1—Prednisone—chronic obstructive pulmonary disease	0.00984	0.0293	CbGbCtD
Lansoprazole—CYP3A4—Prednisolone—chronic obstructive pulmonary disease	0.00625	0.0186	CbGbCtD
Lansoprazole—CYP3A4—Prednisone—chronic obstructive pulmonary disease	0.0059	0.0176	CbGbCtD
Lansoprazole—Thiabendazole—CYP1A1—chronic obstructive pulmonary disease	0.00151	0.295	CrCbGaD
Lansoprazole—Thiabendazole—CYP1A2—chronic obstructive pulmonary disease	0.00146	0.285	CrCbGaD
Lansoprazole—Rabeprazole—CYP1A1—chronic obstructive pulmonary disease	0.000475	0.0929	CrCbGaD
Lansoprazole—Pantoprazole—CYP1A2—chronic obstructive pulmonary disease	0.000458	0.0895	CrCbGaD
Lansoprazole—Rabeprazole—CYP1A2—chronic obstructive pulmonary disease	0.000458	0.0895	CrCbGaD
Lansoprazole—Omeprazole—CYP1A1—chronic obstructive pulmonary disease	0.000387	0.0757	CrCbGaD
Lansoprazole—Omeprazole—CYP1A2—chronic obstructive pulmonary disease	0.000373	0.073	CrCbGaD
Lansoprazole—Skin disorder—Arformoterol—chronic obstructive pulmonary disease	0.000114	0.000747	CcSEcCtD
Lansoprazole—Hypersensitivity—Aminophylline—chronic obstructive pulmonary disease	0.000113	0.000745	CcSEcCtD
Lansoprazole—Dry mouth—Salbutamol—chronic obstructive pulmonary disease	0.000113	0.000741	CcSEcCtD
Lansoprazole—Hyperkinesia—Prednisone—chronic obstructive pulmonary disease	0.000113	0.00074	CcSEcCtD
Lansoprazole—Nervous system disorder—Montelukast—chronic obstructive pulmonary disease	0.000112	0.000739	CcSEcCtD
Lansoprazole—Thrombocytopenia—Montelukast—chronic obstructive pulmonary disease	0.000112	0.000738	CcSEcCtD
Lansoprazole—Abdominal distension—Prednisolone—chronic obstructive pulmonary disease	0.000112	0.000738	CcSEcCtD
Lansoprazole—Skin disorder—Montelukast—chronic obstructive pulmonary disease	0.000111	0.000732	CcSEcCtD
Lansoprazole—Anaphylactic shock—Salbutamol—chronic obstructive pulmonary disease	0.00011	0.000727	CcSEcCtD
Lansoprazole—Oedema—Salbutamol—chronic obstructive pulmonary disease	0.00011	0.000727	CcSEcCtD
Lansoprazole—Infection—Salbutamol—chronic obstructive pulmonary disease	0.00011	0.000722	CcSEcCtD
Lansoprazole—Hypotension—Formoterol—chronic obstructive pulmonary disease	0.000109	0.000719	CcSEcCtD
Lansoprazole—Hypotension—Arformoterol—chronic obstructive pulmonary disease	0.000109	0.000719	CcSEcCtD
Lansoprazole—Pancreatitis—Prednisolone—chronic obstructive pulmonary disease	0.000109	0.000719	CcSEcCtD
Lansoprazole—Pruritus—Aminophylline—chronic obstructive pulmonary disease	0.000109	0.000715	CcSEcCtD
Lansoprazole—Shock—Salbutamol—chronic obstructive pulmonary disease	0.000109	0.000715	CcSEcCtD
Lansoprazole—Nervous system disorder—Salbutamol—chronic obstructive pulmonary disease	0.000108	0.000713	CcSEcCtD
Lansoprazole—Tachycardia—Salbutamol—chronic obstructive pulmonary disease	0.000108	0.000709	CcSEcCtD
Lansoprazole—Diabetes mellitus—Prednisone—chronic obstructive pulmonary disease	0.000108	0.000708	CcSEcCtD
Lansoprazole—Skin disorder—Salbutamol—chronic obstructive pulmonary disease	0.000107	0.000706	CcSEcCtD
Lansoprazole—Hypersensitivity—Tiotropium—chronic obstructive pulmonary disease	0.000107	0.000703	CcSEcCtD
Lansoprazole—Hyperhidrosis—Salbutamol—chronic obstructive pulmonary disease	0.000107	0.000702	CcSEcCtD
Lansoprazole—Musculoskeletal discomfort—Arformoterol—chronic obstructive pulmonary disease	0.000107	0.000701	CcSEcCtD
Lansoprazole—Musculoskeletal discomfort—Formoterol—chronic obstructive pulmonary disease	0.000107	0.000701	CcSEcCtD
Lansoprazole—Insomnia—Arformoterol—chronic obstructive pulmonary disease	0.000106	0.000696	CcSEcCtD
Lansoprazole—Insomnia—Formoterol—chronic obstructive pulmonary disease	0.000106	0.000696	CcSEcCtD
Lansoprazole—Anorexia—Salbutamol—chronic obstructive pulmonary disease	0.000105	0.000693	CcSEcCtD
Lansoprazole—Diarrhoea—Aminophylline—chronic obstructive pulmonary disease	0.000105	0.000692	CcSEcCtD
Lansoprazole—Vascular purpura—Prednisone—chronic obstructive pulmonary disease	0.000105	0.000689	CcSEcCtD
Lansoprazole—Musculoskeletal discomfort—Montelukast—chronic obstructive pulmonary disease	0.000104	0.000687	CcSEcCtD
Lansoprazole—Dyspnoea—Arformoterol—chronic obstructive pulmonary disease	0.000104	0.000686	CcSEcCtD
Lansoprazole—Dyspnoea—Formoterol—chronic obstructive pulmonary disease	0.000104	0.000686	CcSEcCtD
Lansoprazole—Somnolence—Arformoterol—chronic obstructive pulmonary disease	0.000104	0.000684	CcSEcCtD
Lansoprazole—Somnolence—Formoterol—chronic obstructive pulmonary disease	0.000104	0.000684	CcSEcCtD
Lansoprazole—Insomnia—Montelukast—chronic obstructive pulmonary disease	0.000104	0.000682	CcSEcCtD
Lansoprazole—Hypotension—Salbutamol—chronic obstructive pulmonary disease	0.000103	0.000679	CcSEcCtD
Lansoprazole—Dyspepsia—Formoterol—chronic obstructive pulmonary disease	0.000103	0.000677	CcSEcCtD
Lansoprazole—Dyspepsia—Arformoterol—chronic obstructive pulmonary disease	0.000103	0.000677	CcSEcCtD
Lansoprazole—Paraesthesia—Montelukast—chronic obstructive pulmonary disease	0.000103	0.000677	CcSEcCtD
Lansoprazole—Pruritus—Tiotropium—chronic obstructive pulmonary disease	0.000103	0.000675	CcSEcCtD
Lansoprazole—Injury—Prednisone—chronic obstructive pulmonary disease	0.000102	0.00067	CcSEcCtD
Lansoprazole—Somnolence—Montelukast—chronic obstructive pulmonary disease	0.000102	0.00067	CcSEcCtD
Lansoprazole—Dizziness—Aminophylline—chronic obstructive pulmonary disease	0.000102	0.000669	CcSEcCtD
Lansoprazole—Weight increased—Prednisolone—chronic obstructive pulmonary disease	0.000101	0.000667	CcSEcCtD
Lansoprazole—Gastrointestinal disorder—Formoterol—chronic obstructive pulmonary disease	0.000101	0.000664	CcSEcCtD
Lansoprazole—Gastrointestinal disorder—Arformoterol—chronic obstructive pulmonary disease	0.000101	0.000664	CcSEcCtD
Lansoprazole—Dyspepsia—Montelukast—chronic obstructive pulmonary disease	0.000101	0.000663	CcSEcCtD
Lansoprazole—Fatigue—Formoterol—chronic obstructive pulmonary disease	0.000101	0.000663	CcSEcCtD
Lansoprazole—Fatigue—Arformoterol—chronic obstructive pulmonary disease	0.000101	0.000663	CcSEcCtD
Lansoprazole—Musculoskeletal discomfort—Salbutamol—chronic obstructive pulmonary disease	0.000101	0.000662	CcSEcCtD
Lansoprazole—Constipation—Formoterol—chronic obstructive pulmonary disease	0.0001	0.000658	CcSEcCtD
Lansoprazole—Pain—Arformoterol—chronic obstructive pulmonary disease	0.0001	0.000658	CcSEcCtD
Lansoprazole—Pain—Formoterol—chronic obstructive pulmonary disease	0.0001	0.000658	CcSEcCtD
Lansoprazole—Constipation—Arformoterol—chronic obstructive pulmonary disease	0.0001	0.000658	CcSEcCtD
Lansoprazole—Insomnia—Salbutamol—chronic obstructive pulmonary disease	9.99e-05	0.000657	CcSEcCtD
Lansoprazole—Amnesia—Prednisone—chronic obstructive pulmonary disease	9.97e-05	0.000656	CcSEcCtD
Lansoprazole—Increased appetite—Prednisone—chronic obstructive pulmonary disease	9.97e-05	0.000656	CcSEcCtD
Lansoprazole—Paraesthesia—Salbutamol—chronic obstructive pulmonary disease	9.92e-05	0.000652	CcSEcCtD
Lansoprazole—Gastrointestinal disorder—Montelukast—chronic obstructive pulmonary disease	9.9e-05	0.000651	CcSEcCtD
Lansoprazole—Fatigue—Montelukast—chronic obstructive pulmonary disease	9.88e-05	0.00065	CcSEcCtD
Lansoprazole—Dyspnoea—Salbutamol—chronic obstructive pulmonary disease	9.85e-05	0.000648	CcSEcCtD
Lansoprazole—Somnolence—Salbutamol—chronic obstructive pulmonary disease	9.82e-05	0.000646	CcSEcCtD
Lansoprazole—Pain—Montelukast—chronic obstructive pulmonary disease	9.8e-05	0.000645	CcSEcCtD
Lansoprazole—Acute coronary syndrome—Prednisolone—chronic obstructive pulmonary disease	9.8e-05	0.000644	CcSEcCtD
Lansoprazole—Vomiting—Aminophylline—chronic obstructive pulmonary disease	9.78e-05	0.000643	CcSEcCtD
Lansoprazole—Myocardial infarction—Prednisolone—chronic obstructive pulmonary disease	9.74e-05	0.000641	CcSEcCtD
Lansoprazole—Neuropathy peripheral—Prednisolone—chronic obstructive pulmonary disease	9.74e-05	0.000641	CcSEcCtD
Lansoprazole—Dyspepsia—Salbutamol—chronic obstructive pulmonary disease	9.73e-05	0.00064	CcSEcCtD
Lansoprazole—Purpura—Prednisone—chronic obstructive pulmonary disease	9.72e-05	0.000639	CcSEcCtD
Lansoprazole—Rash—Aminophylline—chronic obstructive pulmonary disease	9.69e-05	0.000638	CcSEcCtD
Lansoprazole—Dermatitis—Aminophylline—chronic obstructive pulmonary disease	9.69e-05	0.000637	CcSEcCtD
Lansoprazole—Conjunctivitis—Prednisolone—chronic obstructive pulmonary disease	9.66e-05	0.000635	CcSEcCtD
Lansoprazole—Feeling abnormal—Formoterol—chronic obstructive pulmonary disease	9.64e-05	0.000634	CcSEcCtD
Lansoprazole—Feeling abnormal—Arformoterol—chronic obstructive pulmonary disease	9.64e-05	0.000634	CcSEcCtD
Lansoprazole—Headache—Aminophylline—chronic obstructive pulmonary disease	9.63e-05	0.000633	CcSEcCtD
Lansoprazole—Decreased appetite—Salbutamol—chronic obstructive pulmonary disease	9.61e-05	0.000632	CcSEcCtD
Lansoprazole—Dizziness—Tiotropium—chronic obstructive pulmonary disease	9.59e-05	0.000631	CcSEcCtD
Lansoprazole—Gastrointestinal pain—Formoterol—chronic obstructive pulmonary disease	9.57e-05	0.000629	CcSEcCtD
Lansoprazole—Gastrointestinal pain—Arformoterol—chronic obstructive pulmonary disease	9.57e-05	0.000629	CcSEcCtD
Lansoprazole—Gastrointestinal disorder—Salbutamol—chronic obstructive pulmonary disease	9.54e-05	0.000627	CcSEcCtD
Lansoprazole—Fatigue—Salbutamol—chronic obstructive pulmonary disease	9.53e-05	0.000626	CcSEcCtD
Lansoprazole—Constipation—Salbutamol—chronic obstructive pulmonary disease	9.45e-05	0.000621	CcSEcCtD
Lansoprazole—Pain—Salbutamol—chronic obstructive pulmonary disease	9.45e-05	0.000621	CcSEcCtD
Lansoprazole—Gastrointestinal pain—Montelukast—chronic obstructive pulmonary disease	9.37e-05	0.000616	CcSEcCtD
Lansoprazole—Osteoarthritis—Prednisone—chronic obstructive pulmonary disease	9.37e-05	0.000616	CcSEcCtD
Lansoprazole—Gastrointestinal haemorrhage—Prednisone—chronic obstructive pulmonary disease	9.37e-05	0.000616	CcSEcCtD
Lansoprazole—Urticaria—Formoterol—chronic obstructive pulmonary disease	9.3e-05	0.000611	CcSEcCtD
Lansoprazole—Urticaria—Arformoterol—chronic obstructive pulmonary disease	9.3e-05	0.000611	CcSEcCtD
Lansoprazole—Body temperature increased—Arformoterol—chronic obstructive pulmonary disease	9.25e-05	0.000608	CcSEcCtD
Lansoprazole—Body temperature increased—Formoterol—chronic obstructive pulmonary disease	9.25e-05	0.000608	CcSEcCtD
Lansoprazole—Abdominal pain—Formoterol—chronic obstructive pulmonary disease	9.25e-05	0.000608	CcSEcCtD
Lansoprazole—Abdominal pain—Arformoterol—chronic obstructive pulmonary disease	9.25e-05	0.000608	CcSEcCtD
Lansoprazole—Affect lability—Prednisone—chronic obstructive pulmonary disease	9.22e-05	0.000606	CcSEcCtD
Lansoprazole—Vomiting—Tiotropium—chronic obstructive pulmonary disease	9.22e-05	0.000606	CcSEcCtD
Lansoprazole—Rash—Tiotropium—chronic obstructive pulmonary disease	9.14e-05	0.000601	CcSEcCtD
Lansoprazole—Dermatitis—Tiotropium—chronic obstructive pulmonary disease	9.13e-05	0.000601	CcSEcCtD
Lansoprazole—Nausea—Aminophylline—chronic obstructive pulmonary disease	9.13e-05	0.000601	CcSEcCtD
Lansoprazole—Urticaria—Montelukast—chronic obstructive pulmonary disease	9.11e-05	0.000599	CcSEcCtD
Lansoprazole—Feeling abnormal—Salbutamol—chronic obstructive pulmonary disease	9.11e-05	0.000599	CcSEcCtD
Lansoprazole—Headache—Tiotropium—chronic obstructive pulmonary disease	9.08e-05	0.000597	CcSEcCtD
Lansoprazole—Bradycardia—Prednisolone—chronic obstructive pulmonary disease	9.08e-05	0.000597	CcSEcCtD
Lansoprazole—Abdominal pain—Montelukast—chronic obstructive pulmonary disease	9.06e-05	0.000596	CcSEcCtD
Lansoprazole—Body temperature increased—Montelukast—chronic obstructive pulmonary disease	9.06e-05	0.000596	CcSEcCtD
Lansoprazole—Face oedema—Prednisone—chronic obstructive pulmonary disease	9.05e-05	0.000595	CcSEcCtD
Lansoprazole—Gastrointestinal pain—Salbutamol—chronic obstructive pulmonary disease	9.04e-05	0.000594	CcSEcCtD
Lansoprazole—Mood swings—Prednisone—chronic obstructive pulmonary disease	8.88e-05	0.000584	CcSEcCtD
Lansoprazole—Urticaria—Salbutamol—chronic obstructive pulmonary disease	8.78e-05	0.000577	CcSEcCtD
Lansoprazole—Abdominal pain—Salbutamol—chronic obstructive pulmonary disease	8.73e-05	0.000574	CcSEcCtD
Lansoprazole—Body temperature increased—Salbutamol—chronic obstructive pulmonary disease	8.73e-05	0.000574	CcSEcCtD
Lansoprazole—Hypersensitivity—Arformoterol—chronic obstructive pulmonary disease	8.62e-05	0.000567	CcSEcCtD
Lansoprazole—Hypersensitivity—Formoterol—chronic obstructive pulmonary disease	8.62e-05	0.000567	CcSEcCtD
Lansoprazole—Nausea—Tiotropium—chronic obstructive pulmonary disease	8.61e-05	0.000566	CcSEcCtD
Lansoprazole—Visual impairment—Prednisolone—chronic obstructive pulmonary disease	8.6e-05	0.000565	CcSEcCtD
Lansoprazole—Dry skin—Prednisone—chronic obstructive pulmonary disease	8.59e-05	0.000565	CcSEcCtD
Lansoprazole—Hypokalaemia—Prednisone—chronic obstructive pulmonary disease	8.53e-05	0.000561	CcSEcCtD
Lansoprazole—Hypersensitivity—Montelukast—chronic obstructive pulmonary disease	8.44e-05	0.000555	CcSEcCtD
Lansoprazole—Asthenia—Arformoterol—chronic obstructive pulmonary disease	8.4e-05	0.000552	CcSEcCtD
Lansoprazole—Asthenia—Formoterol—chronic obstructive pulmonary disease	8.4e-05	0.000552	CcSEcCtD
Lansoprazole—Pruritus—Formoterol—chronic obstructive pulmonary disease	8.28e-05	0.000544	CcSEcCtD
Lansoprazole—Pruritus—Arformoterol—chronic obstructive pulmonary disease	8.28e-05	0.000544	CcSEcCtD
Lansoprazole—Alanine aminotransferase increased—Prednisone—chronic obstructive pulmonary disease	8.26e-05	0.000543	CcSEcCtD
Lansoprazole—Muscular weakness—Prednisone—chronic obstructive pulmonary disease	8.26e-05	0.000543	CcSEcCtD
Lansoprazole—Asthenia—Montelukast—chronic obstructive pulmonary disease	8.22e-05	0.000541	CcSEcCtD
Lansoprazole—Abdominal distension—Prednisone—chronic obstructive pulmonary disease	8.15e-05	0.000536	CcSEcCtD
Lansoprazole—Hypersensitivity—Salbutamol—chronic obstructive pulmonary disease	8.14e-05	0.000535	CcSEcCtD
Lansoprazole—Pruritus—Montelukast—chronic obstructive pulmonary disease	8.11e-05	0.000533	CcSEcCtD
Lansoprazole—Diarrhoea—Arformoterol—chronic obstructive pulmonary disease	8.01e-05	0.000527	CcSEcCtD
Lansoprazole—Diarrhoea—Formoterol—chronic obstructive pulmonary disease	8.01e-05	0.000527	CcSEcCtD
Lansoprazole—Arrhythmia—Prednisolone—chronic obstructive pulmonary disease	7.97e-05	0.000524	CcSEcCtD
Lansoprazole—Pancreatitis—Prednisone—chronic obstructive pulmonary disease	7.94e-05	0.000522	CcSEcCtD
Lansoprazole—Asthenia—Salbutamol—chronic obstructive pulmonary disease	7.93e-05	0.000521	CcSEcCtD
Lansoprazole—Diarrhoea—Montelukast—chronic obstructive pulmonary disease	7.84e-05	0.000516	CcSEcCtD
Lansoprazole—Pruritus—Salbutamol—chronic obstructive pulmonary disease	7.82e-05	0.000514	CcSEcCtD
Lansoprazole—Erythema—Prednisolone—chronic obstructive pulmonary disease	7.77e-05	0.000511	CcSEcCtD
Lansoprazole—Dizziness—Formoterol—chronic obstructive pulmonary disease	7.74e-05	0.000509	CcSEcCtD
Lansoprazole—Dizziness—Arformoterol—chronic obstructive pulmonary disease	7.74e-05	0.000509	CcSEcCtD
Lansoprazole—Dizziness—Montelukast—chronic obstructive pulmonary disease	7.58e-05	0.000498	CcSEcCtD
Lansoprazole—Neutropenia—Prednisone—chronic obstructive pulmonary disease	7.57e-05	0.000498	CcSEcCtD
Lansoprazole—Diarrhoea—Salbutamol—chronic obstructive pulmonary disease	7.56e-05	0.000497	CcSEcCtD
Lansoprazole—Erectile dysfunction—Prednisone—chronic obstructive pulmonary disease	7.46e-05	0.00049	CcSEcCtD
Lansoprazole—Vomiting—Formoterol—chronic obstructive pulmonary disease	7.44e-05	0.000489	CcSEcCtD
Lansoprazole—Vomiting—Arformoterol—chronic obstructive pulmonary disease	7.44e-05	0.000489	CcSEcCtD
Lansoprazole—Rash—Formoterol—chronic obstructive pulmonary disease	7.38e-05	0.000485	CcSEcCtD
Lansoprazole—Rash—Arformoterol—chronic obstructive pulmonary disease	7.38e-05	0.000485	CcSEcCtD
Lansoprazole—Dermatitis—Arformoterol—chronic obstructive pulmonary disease	7.37e-05	0.000485	CcSEcCtD
Lansoprazole—Dermatitis—Formoterol—chronic obstructive pulmonary disease	7.37e-05	0.000485	CcSEcCtD
Lansoprazole—Weight increased—Prednisone—chronic obstructive pulmonary disease	7.37e-05	0.000485	CcSEcCtD
Lansoprazole—Headache—Arformoterol—chronic obstructive pulmonary disease	7.33e-05	0.000482	CcSEcCtD
Lansoprazole—Headache—Formoterol—chronic obstructive pulmonary disease	7.33e-05	0.000482	CcSEcCtD
Lansoprazole—Vision blurred—Prednisolone—chronic obstructive pulmonary disease	7.32e-05	0.000481	CcSEcCtD
Lansoprazole—Dizziness—Salbutamol—chronic obstructive pulmonary disease	7.31e-05	0.000481	CcSEcCtD
Lansoprazole—Hyperglycaemia—Prednisone—chronic obstructive pulmonary disease	7.31e-05	0.00048	CcSEcCtD
Lansoprazole—Vomiting—Montelukast—chronic obstructive pulmonary disease	7.29e-05	0.000479	CcSEcCtD
Lansoprazole—Rash—Montelukast—chronic obstructive pulmonary disease	7.23e-05	0.000475	CcSEcCtD
Lansoprazole—Dermatitis—Montelukast—chronic obstructive pulmonary disease	7.22e-05	0.000475	CcSEcCtD
Lansoprazole—Ill-defined disorder—Prednisolone—chronic obstructive pulmonary disease	7.2e-05	0.000474	CcSEcCtD
Lansoprazole—Headache—Montelukast—chronic obstructive pulmonary disease	7.18e-05	0.000472	CcSEcCtD
Lansoprazole—Acute coronary syndrome—Prednisone—chronic obstructive pulmonary disease	7.12e-05	0.000468	CcSEcCtD
Lansoprazole—Angioedema—Prednisolone—chronic obstructive pulmonary disease	7.1e-05	0.000467	CcSEcCtD
Lansoprazole—Myocardial infarction—Prednisone—chronic obstructive pulmonary disease	7.08e-05	0.000465	CcSEcCtD
Lansoprazole—Neuropathy peripheral—Prednisone—chronic obstructive pulmonary disease	7.08e-05	0.000465	CcSEcCtD
Lansoprazole—Vomiting—Salbutamol—chronic obstructive pulmonary disease	7.03e-05	0.000462	CcSEcCtD
Lansoprazole—Malaise—Prednisolone—chronic obstructive pulmonary disease	7e-05	0.000461	CcSEcCtD
Lansoprazole—Vertigo—Prednisolone—chronic obstructive pulmonary disease	6.98e-05	0.000459	CcSEcCtD
Lansoprazole—Rash—Salbutamol—chronic obstructive pulmonary disease	6.97e-05	0.000458	CcSEcCtD
Lansoprazole—Syncope—Prednisolone—chronic obstructive pulmonary disease	6.96e-05	0.000458	CcSEcCtD
Lansoprazole—Dermatitis—Salbutamol—chronic obstructive pulmonary disease	6.96e-05	0.000458	CcSEcCtD
Lansoprazole—Nausea—Formoterol—chronic obstructive pulmonary disease	6.95e-05	0.000457	CcSEcCtD
Lansoprazole—Nausea—Arformoterol—chronic obstructive pulmonary disease	6.95e-05	0.000457	CcSEcCtD
Lansoprazole—Headache—Salbutamol—chronic obstructive pulmonary disease	6.92e-05	0.000455	CcSEcCtD
Lansoprazole—Loss of consciousness—Prednisolone—chronic obstructive pulmonary disease	6.82e-05	0.000449	CcSEcCtD
Lansoprazole—Nausea—Montelukast—chronic obstructive pulmonary disease	6.81e-05	0.000448	CcSEcCtD
Lansoprazole—Convulsion—Prednisolone—chronic obstructive pulmonary disease	6.73e-05	0.000442	CcSEcCtD
Lansoprazole—Hypertension—Prednisolone—chronic obstructive pulmonary disease	6.7e-05	0.000441	CcSEcCtD
Lansoprazole—Bradycardia—Prednisone—chronic obstructive pulmonary disease	6.6e-05	0.000434	CcSEcCtD
Lansoprazole—Nausea—Salbutamol—chronic obstructive pulmonary disease	6.56e-05	0.000432	CcSEcCtD
Lansoprazole—Discomfort—Prednisolone—chronic obstructive pulmonary disease	6.53e-05	0.00043	CcSEcCtD
Lansoprazole—Hallucination—Prednisone—chronic obstructive pulmonary disease	6.45e-05	0.000424	CcSEcCtD
Lansoprazole—Connective tissue disorder—Prednisone—chronic obstructive pulmonary disease	6.37e-05	0.000419	CcSEcCtD
Lansoprazole—Anaphylactic shock—Prednisolone—chronic obstructive pulmonary disease	6.34e-05	0.000417	CcSEcCtD
Lansoprazole—Oedema—Prednisolone—chronic obstructive pulmonary disease	6.34e-05	0.000417	CcSEcCtD
Lansoprazole—Shock—Prednisolone—chronic obstructive pulmonary disease	6.23e-05	0.00041	CcSEcCtD
Lansoprazole—Tachycardia—Prednisolone—chronic obstructive pulmonary disease	6.19e-05	0.000407	CcSEcCtD
Lansoprazole—Hyperhidrosis—Prednisolone—chronic obstructive pulmonary disease	6.13e-05	0.000403	CcSEcCtD
Lansoprazole—Eye disorder—Prednisone—chronic obstructive pulmonary disease	6.06e-05	0.000398	CcSEcCtD
Lansoprazole—Angiopathy—Prednisone—chronic obstructive pulmonary disease	5.88e-05	0.000387	CcSEcCtD
Lansoprazole—Immune system disorder—Prednisone—chronic obstructive pulmonary disease	5.85e-05	0.000385	CcSEcCtD
Lansoprazole—Arrhythmia—Prednisone—chronic obstructive pulmonary disease	5.79e-05	0.000381	CcSEcCtD
Lansoprazole—Insomnia—Prednisolone—chronic obstructive pulmonary disease	5.73e-05	0.000377	CcSEcCtD
Lansoprazole—Alopecia—Prednisone—chronic obstructive pulmonary disease	5.73e-05	0.000377	CcSEcCtD
Lansoprazole—Paraesthesia—Prednisolone—chronic obstructive pulmonary disease	5.69e-05	0.000374	CcSEcCtD
Lansoprazole—Mental disorder—Prednisone—chronic obstructive pulmonary disease	5.68e-05	0.000373	CcSEcCtD
Lansoprazole—Erythema—Prednisone—chronic obstructive pulmonary disease	5.64e-05	0.000371	CcSEcCtD
Lansoprazole—Malnutrition—Prednisone—chronic obstructive pulmonary disease	5.64e-05	0.000371	CcSEcCtD
Lansoprazole—Pain—Prednisolone—chronic obstructive pulmonary disease	5.42e-05	0.000356	CcSEcCtD
Lansoprazole—Vision blurred—Prednisone—chronic obstructive pulmonary disease	5.32e-05	0.00035	CcSEcCtD
Lansoprazole—Ill-defined disorder—Prednisone—chronic obstructive pulmonary disease	5.24e-05	0.000344	CcSEcCtD
Lansoprazole—Feeling abnormal—Prednisolone—chronic obstructive pulmonary disease	5.22e-05	0.000343	CcSEcCtD
Lansoprazole—Anaemia—Prednisone—chronic obstructive pulmonary disease	5.22e-05	0.000343	CcSEcCtD
Lansoprazole—Agitation—Prednisone—chronic obstructive pulmonary disease	5.19e-05	0.000341	CcSEcCtD
Lansoprazole—Angioedema—Prednisone—chronic obstructive pulmonary disease	5.16e-05	0.000339	CcSEcCtD
Lansoprazole—Malaise—Prednisone—chronic obstructive pulmonary disease	5.09e-05	0.000335	CcSEcCtD
Lansoprazole—Vertigo—Prednisone—chronic obstructive pulmonary disease	5.07e-05	0.000333	CcSEcCtD
Lansoprazole—Syncope—Prednisone—chronic obstructive pulmonary disease	5.06e-05	0.000333	CcSEcCtD
Lansoprazole—Urticaria—Prednisolone—chronic obstructive pulmonary disease	5.03e-05	0.000331	CcSEcCtD
Lansoprazole—Loss of consciousness—Prednisone—chronic obstructive pulmonary disease	4.96e-05	0.000326	CcSEcCtD
Lansoprazole—Convulsion—Prednisone—chronic obstructive pulmonary disease	4.89e-05	0.000322	CcSEcCtD
Lansoprazole—Hypertension—Prednisone—chronic obstructive pulmonary disease	4.87e-05	0.00032	CcSEcCtD
Lansoprazole—Myalgia—Prednisone—chronic obstructive pulmonary disease	4.8e-05	0.000316	CcSEcCtD
Lansoprazole—Arthralgia—Prednisone—chronic obstructive pulmonary disease	4.8e-05	0.000316	CcSEcCtD
Lansoprazole—Anxiety—Prednisone—chronic obstructive pulmonary disease	4.79e-05	0.000315	CcSEcCtD
Lansoprazole—Unspecified disorder of skin and subcutaneous tissue—Prednisone—chronic obstructive pulmonary disease	4.77e-05	0.000314	CcSEcCtD
Lansoprazole—Discomfort—Prednisone—chronic obstructive pulmonary disease	4.75e-05	0.000312	CcSEcCtD
Lansoprazole—Hypersensitivity—Prednisolone—chronic obstructive pulmonary disease	4.67e-05	0.000307	CcSEcCtD
Lansoprazole—Anaphylactic shock—Prednisone—chronic obstructive pulmonary disease	4.61e-05	0.000303	CcSEcCtD
Lansoprazole—Oedema—Prednisone—chronic obstructive pulmonary disease	4.61e-05	0.000303	CcSEcCtD
Lansoprazole—Infection—Prednisone—chronic obstructive pulmonary disease	4.58e-05	0.000301	CcSEcCtD
Lansoprazole—Shock—Prednisone—chronic obstructive pulmonary disease	4.53e-05	0.000298	CcSEcCtD
Lansoprazole—Nervous system disorder—Prednisone—chronic obstructive pulmonary disease	4.52e-05	0.000297	CcSEcCtD
Lansoprazole—Tachycardia—Prednisone—chronic obstructive pulmonary disease	4.49e-05	0.000296	CcSEcCtD
Lansoprazole—Skin disorder—Prednisone—chronic obstructive pulmonary disease	4.47e-05	0.000294	CcSEcCtD
Lansoprazole—Hyperhidrosis—Prednisone—chronic obstructive pulmonary disease	4.45e-05	0.000293	CcSEcCtD
Lansoprazole—Anorexia—Prednisone—chronic obstructive pulmonary disease	4.39e-05	0.000289	CcSEcCtD
Lansoprazole—Musculoskeletal discomfort—Prednisone—chronic obstructive pulmonary disease	4.2e-05	0.000276	CcSEcCtD
Lansoprazole—Dizziness—Prednisolone—chronic obstructive pulmonary disease	4.19e-05	0.000276	CcSEcCtD
Lansoprazole—Insomnia—Prednisone—chronic obstructive pulmonary disease	4.17e-05	0.000274	CcSEcCtD
Lansoprazole—Paraesthesia—Prednisone—chronic obstructive pulmonary disease	4.14e-05	0.000272	CcSEcCtD
Lansoprazole—Dyspepsia—Prednisone—chronic obstructive pulmonary disease	4.05e-05	0.000267	CcSEcCtD
Lansoprazole—Decreased appetite—Prednisone—chronic obstructive pulmonary disease	4e-05	0.000263	CcSEcCtD
Lansoprazole—Rash—Prednisolone—chronic obstructive pulmonary disease	4e-05	0.000263	CcSEcCtD
Lansoprazole—Dermatitis—Prednisolone—chronic obstructive pulmonary disease	3.99e-05	0.000263	CcSEcCtD
Lansoprazole—Fatigue—Prednisone—chronic obstructive pulmonary disease	3.97e-05	0.000261	CcSEcCtD
Lansoprazole—Headache—Prednisolone—chronic obstructive pulmonary disease	3.97e-05	0.000261	CcSEcCtD
Lansoprazole—Constipation—Prednisone—chronic obstructive pulmonary disease	3.94e-05	0.000259	CcSEcCtD
Lansoprazole—CYP1A1—Metapathway biotransformation—GSTM1—chronic obstructive pulmonary disease	3.82e-05	0.000428	CbGpPWpGaD
Lansoprazole—CYP2C8—Metapathway biotransformation—GSTP1—chronic obstructive pulmonary disease	3.81e-05	0.000427	CbGpPWpGaD
Lansoprazole—CYP2D6—Biological oxidations—CYP1A2—chronic obstructive pulmonary disease	3.8e-05	0.000426	CbGpPWpGaD
Lansoprazole—Feeling abnormal—Prednisone—chronic obstructive pulmonary disease	3.79e-05	0.00025	CcSEcCtD
Lansoprazole—CYP2C9—Biological oxidations—CYP1A2—chronic obstructive pulmonary disease	3.77e-05	0.000423	CbGpPWpGaD
Lansoprazole—Gastrointestinal pain—Prednisone—chronic obstructive pulmonary disease	3.77e-05	0.000248	CcSEcCtD
Lansoprazole—Nausea—Prednisolone—chronic obstructive pulmonary disease	3.76e-05	0.000248	CcSEcCtD
Lansoprazole—CYP2D6—Metapathway biotransformation—CYP1A2—chronic obstructive pulmonary disease	3.75e-05	0.00042	CbGpPWpGaD
Lansoprazole—CYP1A2—Aryl Hydrocarbon Receptor Pathway—IL1B—chronic obstructive pulmonary disease	3.72e-05	0.000417	CbGpPWpGaD
Lansoprazole—CYP2C9—Metapathway biotransformation—CYP1A2—chronic obstructive pulmonary disease	3.71e-05	0.000417	CbGpPWpGaD
Lansoprazole—Urticaria—Prednisone—chronic obstructive pulmonary disease	3.66e-05	0.000241	CcSEcCtD
Lansoprazole—Abdominal pain—Prednisone—chronic obstructive pulmonary disease	3.64e-05	0.000239	CcSEcCtD
Lansoprazole—Body temperature increased—Prednisone—chronic obstructive pulmonary disease	3.64e-05	0.000239	CcSEcCtD
Lansoprazole—CYP4A11—Metabolism of lipids and lipoproteins—CYP1A1—chronic obstructive pulmonary disease	3.55e-05	0.000398	CbGpPWpGaD
Lansoprazole—CYP2C8—Biological oxidations—GSTM1—chronic obstructive pulmonary disease	3.55e-05	0.000398	CbGpPWpGaD
Lansoprazole—CYP2C8—Metapathway biotransformation—GSTM1—chronic obstructive pulmonary disease	3.5e-05	0.000392	CbGpPWpGaD
Lansoprazole—CYP2C19—Metabolism of lipids and lipoproteins—GC—chronic obstructive pulmonary disease	3.49e-05	0.000392	CbGpPWpGaD
Lansoprazole—CYP2C19—Biological oxidations—GSTP1—chronic obstructive pulmonary disease	3.44e-05	0.000387	CbGpPWpGaD
Lansoprazole—CYP1B1—Metabolism of lipids and lipoproteins—CTGF—chronic obstructive pulmonary disease	3.42e-05	0.000383	CbGpPWpGaD
Lansoprazole—CYP2C19—Metapathway biotransformation—GSTP1—chronic obstructive pulmonary disease	3.4e-05	0.000381	CbGpPWpGaD
Lansoprazole—CYP3A4—Phase 1 - Functionalization of compounds—CYP1A1—chronic obstructive pulmonary disease	3.4e-05	0.000381	CbGpPWpGaD
Lansoprazole—Hypersensitivity—Prednisone—chronic obstructive pulmonary disease	3.39e-05	0.000223	CcSEcCtD
Lansoprazole—CYP2C8—Biological oxidations—CYP1A1—chronic obstructive pulmonary disease	3.36e-05	0.000377	CbGpPWpGaD
Lansoprazole—CYP2C8—Metapathway biotransformation—CYP1A1—chronic obstructive pulmonary disease	3.32e-05	0.000372	CbGpPWpGaD
Lansoprazole—Asthenia—Prednisone—chronic obstructive pulmonary disease	3.3e-05	0.000217	CcSEcCtD
Lansoprazole—Pruritus—Prednisone—chronic obstructive pulmonary disease	3.26e-05	0.000214	CcSEcCtD
Lansoprazole—CYP2C9—Metabolism of lipids and lipoproteins—GC—chronic obstructive pulmonary disease	3.19e-05	0.000357	CbGpPWpGaD
Lansoprazole—CYP1B1—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	3.17e-05	0.000356	CbGpPWpGaD
Lansoprazole—CYP2D6—Biological oxidations—GSTP1—chronic obstructive pulmonary disease	3.17e-05	0.000356	CbGpPWpGaD
Lansoprazole—CYP2C19—Biological oxidations—GSTM1—chronic obstructive pulmonary disease	3.17e-05	0.000355	CbGpPWpGaD
Lansoprazole—Diarrhoea—Prednisone—chronic obstructive pulmonary disease	3.15e-05	0.000207	CcSEcCtD
Lansoprazole—ABCB1—Allograft Rejection—CXCL8—chronic obstructive pulmonary disease	3.15e-05	0.000353	CbGpPWpGaD
Lansoprazole—CYP1B1—Metabolism of lipids and lipoproteins—CYP1A2—chronic obstructive pulmonary disease	3.15e-05	0.000353	CbGpPWpGaD
Lansoprazole—CYP1A2—Aryl Hydrocarbon Receptor—VEGFA—chronic obstructive pulmonary disease	3.15e-05	0.000353	CbGpPWpGaD
Lansoprazole—CYP2C9—Biological oxidations—GSTP1—chronic obstructive pulmonary disease	3.14e-05	0.000352	CbGpPWpGaD
Lansoprazole—CYP2D6—Metapathway biotransformation—GSTP1—chronic obstructive pulmonary disease	3.12e-05	0.000351	CbGpPWpGaD
Lansoprazole—CYP2C19—Metapathway biotransformation—GSTM1—chronic obstructive pulmonary disease	3.12e-05	0.00035	CbGpPWpGaD
Lansoprazole—CYP2C9—Metapathway biotransformation—GSTP1—chronic obstructive pulmonary disease	3.1e-05	0.000348	CbGpPWpGaD
Lansoprazole—CYP1B1—Metabolism—GC—chronic obstructive pulmonary disease	3.09e-05	0.000346	CbGpPWpGaD
Lansoprazole—Dizziness—Prednisone—chronic obstructive pulmonary disease	3.05e-05	0.0002	CcSEcCtD
Lansoprazole—ABCB1—Allograft Rejection—IL1B—chronic obstructive pulmonary disease	3.02e-05	0.000339	CbGpPWpGaD
Lansoprazole—CYP2C19—Biological oxidations—CYP1A1—chronic obstructive pulmonary disease	3e-05	0.000337	CbGpPWpGaD
Lansoprazole—CYP3A4—Biological oxidations—GSTT1—chronic obstructive pulmonary disease	2.99e-05	0.000335	CbGpPWpGaD
Lansoprazole—CYP2C19—Metapathway biotransformation—CYP1A1—chronic obstructive pulmonary disease	2.96e-05	0.000332	CbGpPWpGaD
Lansoprazole—CYP3A4—Biological oxidations—GCLC—chronic obstructive pulmonary disease	2.95e-05	0.000331	CbGpPWpGaD
Lansoprazole—ABCB1—HIF-1-alpha transcription factor network—VEGFA—chronic obstructive pulmonary disease	2.95e-05	0.000331	CbGpPWpGaD
Lansoprazole—CYP1A1—Metabolism—APIP—chronic obstructive pulmonary disease	2.95e-05	0.000331	CbGpPWpGaD
Lansoprazole—Vomiting—Prednisone—chronic obstructive pulmonary disease	2.93e-05	0.000193	CcSEcCtD
Lansoprazole—CYP2D6—Biological oxidations—GSTM1—chronic obstructive pulmonary disease	2.91e-05	0.000327	CbGpPWpGaD
Lansoprazole—Rash—Prednisone—chronic obstructive pulmonary disease	2.9e-05	0.000191	CcSEcCtD
Lansoprazole—Dermatitis—Prednisone—chronic obstructive pulmonary disease	2.9e-05	0.000191	CcSEcCtD
Lansoprazole—CYP1A2—Aryl Hydrocarbon Receptor Pathway—TGFB1—chronic obstructive pulmonary disease	2.89e-05	0.000324	CbGpPWpGaD
Lansoprazole—ABCG2—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	2.89e-05	0.000324	CbGpPWpGaD
Lansoprazole—CYP2C9—Biological oxidations—GSTM1—chronic obstructive pulmonary disease	2.89e-05	0.000324	CbGpPWpGaD
Lansoprazole—Headache—Prednisone—chronic obstructive pulmonary disease	2.88e-05	0.00019	CcSEcCtD
Lansoprazole—CYP2D6—Metapathway biotransformation—GSTM1—chronic obstructive pulmonary disease	2.87e-05	0.000322	CbGpPWpGaD
Lansoprazole—CYP1B1—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	2.87e-05	0.000322	CbGpPWpGaD
Lansoprazole—CYP2C9—Metapathway biotransformation—GSTM1—chronic obstructive pulmonary disease	2.85e-05	0.000319	CbGpPWpGaD
Lansoprazole—CYP1A2—Aryl Hydrocarbon Receptor—EGFR—chronic obstructive pulmonary disease	2.83e-05	0.000318	CbGpPWpGaD
Lansoprazole—CYP1A2—Aryl Hydrocarbon Receptor Pathway—EGFR—chronic obstructive pulmonary disease	2.83e-05	0.000318	CbGpPWpGaD
Lansoprazole—ABCG2—Metabolism—GC—chronic obstructive pulmonary disease	2.81e-05	0.000315	CbGpPWpGaD
Lansoprazole—CYP2D6—Biological oxidations—CYP1A1—chronic obstructive pulmonary disease	2.76e-05	0.00031	CbGpPWpGaD
Lansoprazole—CYP2C9—Biological oxidations—CYP1A1—chronic obstructive pulmonary disease	2.74e-05	0.000307	CbGpPWpGaD
Lansoprazole—Nausea—Prednisone—chronic obstructive pulmonary disease	2.74e-05	0.00018	CcSEcCtD
Lansoprazole—CYP2D6—Metapathway biotransformation—CYP1A1—chronic obstructive pulmonary disease	2.72e-05	0.000305	CbGpPWpGaD
Lansoprazole—CYP1A2—Metabolism of lipids and lipoproteins—GC—chronic obstructive pulmonary disease	2.72e-05	0.000305	CbGpPWpGaD
Lansoprazole—CYP2C8—Metabolism—APIP—chronic obstructive pulmonary disease	2.7e-05	0.000304	CbGpPWpGaD
Lansoprazole—CYP2C9—Metapathway biotransformation—CYP1A1—chronic obstructive pulmonary disease	2.7e-05	0.000303	CbGpPWpGaD
Lansoprazole—CYP1A2—Aryl Hydrocarbon Receptor Pathway—TNF—chronic obstructive pulmonary disease	2.7e-05	0.000303	CbGpPWpGaD
Lansoprazole—CYP1A2—Aryl Hydrocarbon Receptor—TNF—chronic obstructive pulmonary disease	2.7e-05	0.000303	CbGpPWpGaD
Lansoprazole—CYP1A2—Biological oxidations—GSTP1—chronic obstructive pulmonary disease	2.68e-05	0.000301	CbGpPWpGaD
Lansoprazole—CYP1A2—Metapathway biotransformation—GSTP1—chronic obstructive pulmonary disease	2.65e-05	0.000297	CbGpPWpGaD
Lansoprazole—CYP4A11—Metabolism—GSTT1—chronic obstructive pulmonary disease	2.62e-05	0.000294	CbGpPWpGaD
Lansoprazole—ABCG2—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	2.61e-05	0.000293	CbGpPWpGaD
Lansoprazole—CYP4A11—Metabolism—GCLC—chronic obstructive pulmonary disease	2.59e-05	0.00029	CbGpPWpGaD
Lansoprazole—ABCB1—Allograft Rejection—VEGFA—chronic obstructive pulmonary disease	2.56e-05	0.000287	CbGpPWpGaD
Lansoprazole—CYP3A4—Biological oxidations—CYP1A2—chronic obstructive pulmonary disease	2.48e-05	0.000279	CbGpPWpGaD
Lansoprazole—CYP1A2—Biological oxidations—GSTM1—chronic obstructive pulmonary disease	2.47e-05	0.000277	CbGpPWpGaD
Lansoprazole—CYP3A4—Metapathway biotransformation—CYP1A2—chronic obstructive pulmonary disease	2.45e-05	0.000275	CbGpPWpGaD
Lansoprazole—CYP1A2—Metapathway biotransformation—GSTM1—chronic obstructive pulmonary disease	2.43e-05	0.000273	CbGpPWpGaD
Lansoprazole—CYP2C19—Metabolism—APIP—chronic obstructive pulmonary disease	2.41e-05	0.000271	CbGpPWpGaD
Lansoprazole—CYP4A11—Metabolism of lipids and lipoproteins—ALB—chronic obstructive pulmonary disease	2.41e-05	0.000271	CbGpPWpGaD
Lansoprazole—CYP4A11—Metabolism—CTGF—chronic obstructive pulmonary disease	2.36e-05	0.000265	CbGpPWpGaD
Lansoprazole—ABCB1—Metabolism—APIP—chronic obstructive pulmonary disease	2.36e-05	0.000264	CbGpPWpGaD
Lansoprazole—ABCB1—Allograft Rejection—TGFB1—chronic obstructive pulmonary disease	2.35e-05	0.000263	CbGpPWpGaD
Lansoprazole—CYP1A2—Biological oxidations—CYP1A1—chronic obstructive pulmonary disease	2.34e-05	0.000262	CbGpPWpGaD
Lansoprazole—CYP1A2—Metapathway biotransformation—CYP1A1—chronic obstructive pulmonary disease	2.31e-05	0.000259	CbGpPWpGaD
Lansoprazole—CYP2C18—Metabolism—GSTT1—chronic obstructive pulmonary disease	2.29e-05	0.000257	CbGpPWpGaD
Lansoprazole—CYP1B1—Metabolism of lipids and lipoproteins—CYP1A1—chronic obstructive pulmonary disease	2.29e-05	0.000257	CbGpPWpGaD
Lansoprazole—CYP2C18—Metabolism—GCLC—chronic obstructive pulmonary disease	2.26e-05	0.000254	CbGpPWpGaD
Lansoprazole—ABCG2—Transmembrane transport of small molecules—HMOX1—chronic obstructive pulmonary disease	2.24e-05	0.000251	CbGpPWpGaD
Lansoprazole—CYP2D6—Metabolism—APIP—chronic obstructive pulmonary disease	2.22e-05	0.000249	CbGpPWpGaD
Lansoprazole—CYP2C9—Metabolism—APIP—chronic obstructive pulmonary disease	2.2e-05	0.000247	CbGpPWpGaD
Lansoprazole—ABCB1—Allograft Rejection—TNF—chronic obstructive pulmonary disease	2.19e-05	0.000246	CbGpPWpGaD
Lansoprazole—CYP4A11—Metabolism—CYP1A2—chronic obstructive pulmonary disease	2.18e-05	0.000244	CbGpPWpGaD
Lansoprazole—CYP1A1—Metabolism of lipids and lipoproteins—CTGF—chronic obstructive pulmonary disease	2.1e-05	0.000236	CbGpPWpGaD
Lansoprazole—CYP3A4—Biological oxidations—GSTP1—chronic obstructive pulmonary disease	2.07e-05	0.000232	CbGpPWpGaD
Lansoprazole—CYP2C18—Metabolism—CTGF—chronic obstructive pulmonary disease	2.06e-05	0.000232	CbGpPWpGaD
Lansoprazole—CYP3A4—Metapathway biotransformation—GSTP1—chronic obstructive pulmonary disease	2.04e-05	0.000229	CbGpPWpGaD
Lansoprazole—CYP1A1—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	1.95e-05	0.000219	CbGpPWpGaD
Lansoprazole—CYP1A1—Metabolism of lipids and lipoproteins—CYP1A2—chronic obstructive pulmonary disease	1.94e-05	0.000217	CbGpPWpGaD
Lansoprazole—CYP2C8—Metabolism of lipids and lipoproteins—CTGF—chronic obstructive pulmonary disease	1.93e-05	0.000216	CbGpPWpGaD
Lansoprazole—CYP3A4—Biological oxidations—GSTM1—chronic obstructive pulmonary disease	1.9e-05	0.000214	CbGpPWpGaD
Lansoprazole—CYP1A1—Metabolism—GC—chronic obstructive pulmonary disease	1.9e-05	0.000213	CbGpPWpGaD
Lansoprazole—CYP2C18—Metabolism—CYP1A2—chronic obstructive pulmonary disease	1.9e-05	0.000213	CbGpPWpGaD
Lansoprazole—CYP1A2—Metabolism—APIP—chronic obstructive pulmonary disease	1.88e-05	0.000211	CbGpPWpGaD
Lansoprazole—CYP3A4—Metapathway biotransformation—GSTM1—chronic obstructive pulmonary disease	1.88e-05	0.000211	CbGpPWpGaD
Lansoprazole—CYP4A11—Metabolism—GSTP1—chronic obstructive pulmonary disease	1.81e-05	0.000204	CbGpPWpGaD
Lansoprazole—CYP3A4—Biological oxidations—CYP1A1—chronic obstructive pulmonary disease	1.8e-05	0.000202	CbGpPWpGaD
Lansoprazole—CYP2C8—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	1.79e-05	0.000201	CbGpPWpGaD
Lansoprazole—CYP4A11—Metabolism—HMOX1—chronic obstructive pulmonary disease	1.79e-05	0.000201	CbGpPWpGaD
Lansoprazole—CYP3A4—Metapathway biotransformation—CYP1A1—chronic obstructive pulmonary disease	1.78e-05	0.0002	CbGpPWpGaD
Lansoprazole—CYP2C8—Metabolism of lipids and lipoproteins—CYP1A2—chronic obstructive pulmonary disease	1.78e-05	0.000199	CbGpPWpGaD
Lansoprazole—CYP1A1—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	1.77e-05	0.000198	CbGpPWpGaD
Lansoprazole—CYP2C8—Metabolism—GC—chronic obstructive pulmonary disease	1.74e-05	0.000196	CbGpPWpGaD
Lansoprazole—CYP2C19—Metabolism of lipids and lipoproteins—CTGF—chronic obstructive pulmonary disease	1.72e-05	0.000193	CbGpPWpGaD
Lansoprazole—CYP1B1—Metabolism—GSTT1—chronic obstructive pulmonary disease	1.69e-05	0.000189	CbGpPWpGaD
Lansoprazole—CYP1B1—Metabolism—GCLC—chronic obstructive pulmonary disease	1.67e-05	0.000187	CbGpPWpGaD
Lansoprazole—CYP4A11—Metabolism—GSTM1—chronic obstructive pulmonary disease	1.67e-05	0.000187	CbGpPWpGaD
Lansoprazole—CYP2C8—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	1.62e-05	0.000182	CbGpPWpGaD
Lansoprazole—CYP2C19—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	1.6e-05	0.000179	CbGpPWpGaD
Lansoprazole—CYP2C19—Metabolism of lipids and lipoproteins—CYP1A2—chronic obstructive pulmonary disease	1.59e-05	0.000178	CbGpPWpGaD
Lansoprazole—CYP2C18—Metabolism—GSTP1—chronic obstructive pulmonary disease	1.59e-05	0.000178	CbGpPWpGaD
Lansoprazole—CYP4A11—Metabolism—CYP1A1—chronic obstructive pulmonary disease	1.58e-05	0.000177	CbGpPWpGaD
Lansoprazole—CYP2C9—Metabolism of lipids and lipoproteins—CTGF—chronic obstructive pulmonary disease	1.57e-05	0.000176	CbGpPWpGaD
Lansoprazole—CYP2C18—Metabolism—HMOX1—chronic obstructive pulmonary disease	1.56e-05	0.000175	CbGpPWpGaD
Lansoprazole—ABCB1—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	1.56e-05	0.000175	CbGpPWpGaD
Lansoprazole—CYP2C19—Metabolism—GC—chronic obstructive pulmonary disease	1.56e-05	0.000175	CbGpPWpGaD
Lansoprazole—CYP1B1—Metabolism of lipids and lipoproteins—ALB—chronic obstructive pulmonary disease	1.55e-05	0.000174	CbGpPWpGaD
Lansoprazole—ABCG2—Metabolism—GSTT1—chronic obstructive pulmonary disease	1.53e-05	0.000172	CbGpPWpGaD
Lansoprazole—CYP1B1—Metabolism—CTGF—chronic obstructive pulmonary disease	1.52e-05	0.000171	CbGpPWpGaD
Lansoprazole—ABCB1—Metabolism—GC—chronic obstructive pulmonary disease	1.52e-05	0.00017	CbGpPWpGaD
Lansoprazole—ABCG2—Metabolism—GCLC—chronic obstructive pulmonary disease	1.52e-05	0.00017	CbGpPWpGaD
Lansoprazole—CYP2D6—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	1.47e-05	0.000165	CbGpPWpGaD
Lansoprazole—CYP2C9—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	1.46e-05	0.000164	CbGpPWpGaD
Lansoprazole—CYP2C18—Metabolism—GSTM1—chronic obstructive pulmonary disease	1.46e-05	0.000164	CbGpPWpGaD
Lansoprazole—CYP3A4—Metabolism—APIP—chronic obstructive pulmonary disease	1.45e-05	0.000163	CbGpPWpGaD
Lansoprazole—CYP2C19—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	1.45e-05	0.000162	CbGpPWpGaD
Lansoprazole—CYP2C9—Metabolism of lipids and lipoproteins—CYP1A2—chronic obstructive pulmonary disease	1.45e-05	0.000162	CbGpPWpGaD
Lansoprazole—CYP2D6—Metabolism—GC—chronic obstructive pulmonary disease	1.43e-05	0.000161	CbGpPWpGaD
Lansoprazole—CYP2C9—Metabolism—GC—chronic obstructive pulmonary disease	1.42e-05	0.000159	CbGpPWpGaD
Lansoprazole—ABCB1—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	1.41e-05	0.000158	CbGpPWpGaD
Lansoprazole—CYP1B1—Metabolism—CYP1A2—chronic obstructive pulmonary disease	1.4e-05	0.000157	CbGpPWpGaD
Lansoprazole—ABCG2—Metabolism—CTGF—chronic obstructive pulmonary disease	1.38e-05	0.000155	CbGpPWpGaD
Lansoprazole—CYP2C18—Metabolism—CYP1A1—chronic obstructive pulmonary disease	1.38e-05	0.000155	CbGpPWpGaD
Lansoprazole—ABCG2—Transmembrane transport of small molecules—ALB—chronic obstructive pulmonary disease	1.34e-05	0.000151	CbGpPWpGaD
Lansoprazole—CYP1A2—Metabolism of lipids and lipoproteins—CTGF—chronic obstructive pulmonary disease	1.34e-05	0.000151	CbGpPWpGaD
Lansoprazole—CYP2D6—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	1.33e-05	0.000149	CbGpPWpGaD
Lansoprazole—CYP2C9—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	1.32e-05	0.000148	CbGpPWpGaD
Lansoprazole—CYP2C8—Metabolism of lipids and lipoproteins—CYP1A1—chronic obstructive pulmonary disease	1.29e-05	0.000145	CbGpPWpGaD
Lansoprazole—ABCG2—Metabolism—CYP1A2—chronic obstructive pulmonary disease	1.28e-05	0.000143	CbGpPWpGaD
Lansoprazole—ABCB1—Integrated Pancreatic Cancer Pathway—VEGFA—chronic obstructive pulmonary disease	1.26e-05	0.000142	CbGpPWpGaD
Lansoprazole—CYP1A2—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	1.25e-05	0.00014	CbGpPWpGaD
Lansoprazole—CYP1A2—Metabolism—GC—chronic obstructive pulmonary disease	1.21e-05	0.000136	CbGpPWpGaD
Lansoprazole—ABCB1—Transmembrane transport of small molecules—HMOX1—chronic obstructive pulmonary disease	1.21e-05	0.000136	CbGpPWpGaD
Lansoprazole—CYP1B1—Metabolism—GSTP1—chronic obstructive pulmonary disease	1.17e-05	0.000131	CbGpPWpGaD
Lansoprazole—ABCB1—Integrated Pancreatic Cancer Pathway—TGFB1—chronic obstructive pulmonary disease	1.16e-05	0.00013	CbGpPWpGaD
Lansoprazole—CYP1B1—Metabolism—HMOX1—chronic obstructive pulmonary disease	1.15e-05	0.000129	CbGpPWpGaD
Lansoprazole—CYP2C19—Metabolism of lipids and lipoproteins—CYP1A1—chronic obstructive pulmonary disease	1.15e-05	0.000129	CbGpPWpGaD
Lansoprazole—ABCB1—Integrated Pancreatic Cancer Pathway—EGFR—chronic obstructive pulmonary disease	1.14e-05	0.000127	CbGpPWpGaD
Lansoprazole—CYP1A2—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	1.13e-05	0.000126	CbGpPWpGaD
Lansoprazole—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—chronic obstructive pulmonary disease	1.08e-05	0.000121	CbGpPWpGaD
Lansoprazole—CYP1B1—Metabolism—GSTM1—chronic obstructive pulmonary disease	1.07e-05	0.000121	CbGpPWpGaD
Lansoprazole—CYP4A11—Metabolism—ALB—chronic obstructive pulmonary disease	1.07e-05	0.000121	CbGpPWpGaD
Lansoprazole—ABCG2—Metabolism—GSTP1—chronic obstructive pulmonary disease	1.06e-05	0.000119	CbGpPWpGaD
Lansoprazole—CYP2C9—Metabolism of lipids and lipoproteins—CYP1A1—chronic obstructive pulmonary disease	1.05e-05	0.000118	CbGpPWpGaD
Lansoprazole—ABCG2—Metabolism—HMOX1—chronic obstructive pulmonary disease	1.05e-05	0.000118	CbGpPWpGaD
Lansoprazole—CYP1A1—Metabolism—GSTT1—chronic obstructive pulmonary disease	1.04e-05	0.000117	CbGpPWpGaD
Lansoprazole—CYP4A11—Metabolism—NOS3—chronic obstructive pulmonary disease	1.03e-05	0.000115	CbGpPWpGaD
Lansoprazole—CYP1A1—Metabolism—GCLC—chronic obstructive pulmonary disease	1.03e-05	0.000115	CbGpPWpGaD
Lansoprazole—CYP1B1—Metabolism—CYP1A1—chronic obstructive pulmonary disease	1.02e-05	0.000114	CbGpPWpGaD
Lansoprazole—ABCG2—Metabolism—GSTM1—chronic obstructive pulmonary disease	9.77e-06	0.00011	CbGpPWpGaD
Lansoprazole—CYP3A4—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	9.62e-06	0.000108	CbGpPWpGaD
Lansoprazole—CYP1A1—Metabolism of lipids and lipoproteins—ALB—chronic obstructive pulmonary disease	9.57e-06	0.000107	CbGpPWpGaD
Lansoprazole—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—chronic obstructive pulmonary disease	9.53e-06	0.000107	CbGpPWpGaD
Lansoprazole—CYP2C8—Metabolism—GSTT1—chronic obstructive pulmonary disease	9.52e-06	0.000107	CbGpPWpGaD
Lansoprazole—CYP2C8—Metabolism—GCLC—chronic obstructive pulmonary disease	9.41e-06	0.000106	CbGpPWpGaD
Lansoprazole—CYP2C18—Metabolism—ALB—chronic obstructive pulmonary disease	9.39e-06	0.000105	CbGpPWpGaD
Lansoprazole—CYP1A1—Metabolism—CTGF—chronic obstructive pulmonary disease	9.37e-06	0.000105	CbGpPWpGaD
Lansoprazole—CYP3A4—Metabolism—GC—chronic obstructive pulmonary disease	9.36e-06	0.000105	CbGpPWpGaD
Lansoprazole—ABCG2—Metabolism—CYP1A1—chronic obstructive pulmonary disease	9.26e-06	0.000104	CbGpPWpGaD
Lansoprazole—CYP2C18—Metabolism—NOS3—chronic obstructive pulmonary disease	8.98e-06	0.000101	CbGpPWpGaD
Lansoprazole—CYP1A2—Metabolism of lipids and lipoproteins—CYP1A1—chronic obstructive pulmonary disease	8.98e-06	0.000101	CbGpPWpGaD
Lansoprazole—CYP2C8—Metabolism of lipids and lipoproteins—ALB—chronic obstructive pulmonary disease	8.78e-06	9.85e-05	CbGpPWpGaD
Lansoprazole—CYP3A4—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	8.7e-06	9.76e-05	CbGpPWpGaD
Lansoprazole—CYP1A1—Metabolism—CYP1A2—chronic obstructive pulmonary disease	8.63e-06	9.69e-05	CbGpPWpGaD
Lansoprazole—CYP2C8—Metabolism—CTGF—chronic obstructive pulmonary disease	8.59e-06	9.64e-05	CbGpPWpGaD
Lansoprazole—CYP2C19—Metabolism—GSTT1—chronic obstructive pulmonary disease	8.5e-06	9.54e-05	CbGpPWpGaD
Lansoprazole—CYP2C19—Metabolism—GCLC—chronic obstructive pulmonary disease	8.4e-06	9.43e-05	CbGpPWpGaD
Lansoprazole—ABCB1—Metabolism—GSTT1—chronic obstructive pulmonary disease	8.3e-06	9.31e-05	CbGpPWpGaD
Lansoprazole—ABCB1—Metabolism—GCLC—chronic obstructive pulmonary disease	8.2e-06	9.2e-05	CbGpPWpGaD
Lansoprazole—CYP2C8—Metabolism—CYP1A2—chronic obstructive pulmonary disease	7.91e-06	8.88e-05	CbGpPWpGaD
Lansoprazole—CYP2C19—Metabolism of lipids and lipoproteins—ALB—chronic obstructive pulmonary disease	7.83e-06	8.79e-05	CbGpPWpGaD
Lansoprazole—CYP2D6—Metabolism—GSTT1—chronic obstructive pulmonary disease	7.82e-06	8.77e-05	CbGpPWpGaD
Lansoprazole—CYP2C9—Metabolism—GSTT1—chronic obstructive pulmonary disease	7.75e-06	8.7e-05	CbGpPWpGaD
Lansoprazole—CYP2D6—Metabolism—GCLC—chronic obstructive pulmonary disease	7.73e-06	8.67e-05	CbGpPWpGaD
Lansoprazole—CYP2C19—Metabolism—CTGF—chronic obstructive pulmonary disease	7.67e-06	8.6e-05	CbGpPWpGaD
Lansoprazole—CYP2C9—Metabolism—GCLC—chronic obstructive pulmonary disease	7.66e-06	8.6e-05	CbGpPWpGaD
Lansoprazole—ABCB1—Metabolism—CTGF—chronic obstructive pulmonary disease	7.48e-06	8.4e-05	CbGpPWpGaD
Lansoprazole—ABCB1—Transmembrane transport of small molecules—ALB—chronic obstructive pulmonary disease	7.27e-06	8.16e-05	CbGpPWpGaD
Lansoprazole—CYP1A1—Metabolism—GSTP1—chronic obstructive pulmonary disease	7.2e-06	8.08e-05	CbGpPWpGaD
Lansoprazole—CYP2C9—Metabolism of lipids and lipoproteins—ALB—chronic obstructive pulmonary disease	7.14e-06	8.01e-05	CbGpPWpGaD
Lansoprazole—CYP1A1—Metabolism—HMOX1—chronic obstructive pulmonary disease	7.1e-06	7.97e-05	CbGpPWpGaD
Lansoprazole—CYP2C19—Metabolism—CYP1A2—chronic obstructive pulmonary disease	7.06e-06	7.93e-05	CbGpPWpGaD
Lansoprazole—CYP2D6—Metabolism—CTGF—chronic obstructive pulmonary disease	7.05e-06	7.91e-05	CbGpPWpGaD
Lansoprazole—CYP2C9—Metabolism—CTGF—chronic obstructive pulmonary disease	6.99e-06	7.84e-05	CbGpPWpGaD
Lansoprazole—CYP1B1—Metabolism—ALB—chronic obstructive pulmonary disease	6.92e-06	7.77e-05	CbGpPWpGaD
Lansoprazole—ABCB1—Metabolism—CYP1A2—chronic obstructive pulmonary disease	6.89e-06	7.74e-05	CbGpPWpGaD
Lansoprazole—CYP1A2—Metabolism—GSTT1—chronic obstructive pulmonary disease	6.62e-06	7.43e-05	CbGpPWpGaD
Lansoprazole—CYP1B1—Metabolism—NOS3—chronic obstructive pulmonary disease	6.62e-06	7.43e-05	CbGpPWpGaD
Lansoprazole—CYP1A1—Metabolism—GSTM1—chronic obstructive pulmonary disease	6.62e-06	7.42e-05	CbGpPWpGaD
Lansoprazole—CYP2C8—Metabolism—GSTP1—chronic obstructive pulmonary disease	6.6e-06	7.41e-05	CbGpPWpGaD
Lansoprazole—CYP1A2—Metabolism—GCLC—chronic obstructive pulmonary disease	6.55e-06	7.35e-05	CbGpPWpGaD
Lansoprazole—CYP2C8—Metabolism—HMOX1—chronic obstructive pulmonary disease	6.51e-06	7.3e-05	CbGpPWpGaD
Lansoprazole—CYP2D6—Metabolism—CYP1A2—chronic obstructive pulmonary disease	6.5e-06	7.29e-05	CbGpPWpGaD
Lansoprazole—CYP2C9—Metabolism—CYP1A2—chronic obstructive pulmonary disease	6.44e-06	7.23e-05	CbGpPWpGaD
Lansoprazole—ABCG2—Metabolism—ALB—chronic obstructive pulmonary disease	6.3e-06	7.07e-05	CbGpPWpGaD
Lansoprazole—CYP1A2—Metabolism of lipids and lipoproteins—ALB—chronic obstructive pulmonary disease	6.1e-06	6.85e-05	CbGpPWpGaD
Lansoprazole—CYP2C8—Metabolism—GSTM1—chronic obstructive pulmonary disease	6.07e-06	6.81e-05	CbGpPWpGaD
Lansoprazole—ABCG2—Metabolism—NOS3—chronic obstructive pulmonary disease	6.02e-06	6.76e-05	CbGpPWpGaD
Lansoprazole—CYP1A2—Metabolism—CTGF—chronic obstructive pulmonary disease	5.97e-06	6.7e-05	CbGpPWpGaD
Lansoprazole—CYP2C19—Metabolism—GSTP1—chronic obstructive pulmonary disease	5.89e-06	6.61e-05	CbGpPWpGaD
Lansoprazole—CYP2C19—Metabolism—HMOX1—chronic obstructive pulmonary disease	5.81e-06	6.52e-05	CbGpPWpGaD
Lansoprazole—ABCB1—Metabolism—GSTP1—chronic obstructive pulmonary disease	5.75e-06	6.45e-05	CbGpPWpGaD
Lansoprazole—CYP2C8—Metabolism—CYP1A1—chronic obstructive pulmonary disease	5.75e-06	6.45e-05	CbGpPWpGaD
Lansoprazole—ABCB1—Metabolism—HMOX1—chronic obstructive pulmonary disease	5.67e-06	6.36e-05	CbGpPWpGaD
Lansoprazole—CYP2D6—Metabolism—GSTP1—chronic obstructive pulmonary disease	5.42e-06	6.08e-05	CbGpPWpGaD
Lansoprazole—CYP2C19—Metabolism—GSTM1—chronic obstructive pulmonary disease	5.41e-06	6.07e-05	CbGpPWpGaD
Lansoprazole—CYP2C9—Metabolism—GSTP1—chronic obstructive pulmonary disease	5.37e-06	6.03e-05	CbGpPWpGaD
Lansoprazole—CYP2D6—Metabolism—HMOX1—chronic obstructive pulmonary disease	5.34e-06	6e-05	CbGpPWpGaD
Lansoprazole—CYP2C9—Metabolism—HMOX1—chronic obstructive pulmonary disease	5.3e-06	5.94e-05	CbGpPWpGaD
Lansoprazole—ABCB1—Metabolism—GSTM1—chronic obstructive pulmonary disease	5.28e-06	5.93e-05	CbGpPWpGaD
Lansoprazole—CYP2C19—Metabolism—CYP1A1—chronic obstructive pulmonary disease	5.13e-06	5.76e-05	CbGpPWpGaD
Lansoprazole—CYP3A4—Metabolism—GSTT1—chronic obstructive pulmonary disease	5.11e-06	5.73e-05	CbGpPWpGaD
Lansoprazole—CYP3A4—Metabolism—GCLC—chronic obstructive pulmonary disease	5.05e-06	5.67e-05	CbGpPWpGaD
Lansoprazole—ABCB1—Metabolism—CYP1A1—chronic obstructive pulmonary disease	5.01e-06	5.62e-05	CbGpPWpGaD
Lansoprazole—CYP2D6—Metabolism—GSTM1—chronic obstructive pulmonary disease	4.98e-06	5.59e-05	CbGpPWpGaD
Lansoprazole—CYP2C9—Metabolism—GSTM1—chronic obstructive pulmonary disease	4.94e-06	5.54e-05	CbGpPWpGaD
Lansoprazole—CYP2D6—Metabolism—CYP1A1—chronic obstructive pulmonary disease	4.72e-06	5.3e-05	CbGpPWpGaD
Lansoprazole—CYP2C9—Metabolism—CYP1A1—chronic obstructive pulmonary disease	4.68e-06	5.25e-05	CbGpPWpGaD
Lansoprazole—CYP3A4—Metabolism—CTGF—chronic obstructive pulmonary disease	4.61e-06	5.17e-05	CbGpPWpGaD
Lansoprazole—CYP1A2—Metabolism—GSTP1—chronic obstructive pulmonary disease	4.59e-06	5.15e-05	CbGpPWpGaD
Lansoprazole—CYP1A2—Metabolism—HMOX1—chronic obstructive pulmonary disease	4.53e-06	5.08e-05	CbGpPWpGaD
Lansoprazole—CYP1A1—Metabolism—ALB—chronic obstructive pulmonary disease	4.26e-06	4.78e-05	CbGpPWpGaD
Lansoprazole—CYP3A4—Metabolism—CYP1A2—chronic obstructive pulmonary disease	4.25e-06	4.77e-05	CbGpPWpGaD
Lansoprazole—CYP1A2—Metabolism—GSTM1—chronic obstructive pulmonary disease	4.22e-06	4.73e-05	CbGpPWpGaD
Lansoprazole—CYP1A1—Metabolism—NOS3—chronic obstructive pulmonary disease	4.08e-06	4.58e-05	CbGpPWpGaD
Lansoprazole—CYP1A2—Metabolism—CYP1A1—chronic obstructive pulmonary disease	4e-06	4.49e-05	CbGpPWpGaD
Lansoprazole—CYP2C8—Metabolism—ALB—chronic obstructive pulmonary disease	3.91e-06	4.39e-05	CbGpPWpGaD
Lansoprazole—CYP2C8—Metabolism—NOS3—chronic obstructive pulmonary disease	3.74e-06	4.19e-05	CbGpPWpGaD
Lansoprazole—CYP3A4—Metabolism—GSTP1—chronic obstructive pulmonary disease	3.54e-06	3.98e-05	CbGpPWpGaD
Lansoprazole—CYP3A4—Metabolism—HMOX1—chronic obstructive pulmonary disease	3.49e-06	3.92e-05	CbGpPWpGaD
Lansoprazole—CYP2C19—Metabolism—ALB—chronic obstructive pulmonary disease	3.49e-06	3.91e-05	CbGpPWpGaD
Lansoprazole—ABCB1—Metabolism—ALB—chronic obstructive pulmonary disease	3.4e-06	3.82e-05	CbGpPWpGaD
Lansoprazole—CYP2C19—Metabolism—NOS3—chronic obstructive pulmonary disease	3.34e-06	3.74e-05	CbGpPWpGaD
Lansoprazole—ABCB1—Metabolism—NOS3—chronic obstructive pulmonary disease	3.26e-06	3.65e-05	CbGpPWpGaD
Lansoprazole—CYP3A4—Metabolism—GSTM1—chronic obstructive pulmonary disease	3.26e-06	3.65e-05	CbGpPWpGaD
Lansoprazole—CYP2D6—Metabolism—ALB—chronic obstructive pulmonary disease	3.21e-06	3.6e-05	CbGpPWpGaD
Lansoprazole—CYP2C9—Metabolism—ALB—chronic obstructive pulmonary disease	3.18e-06	3.57e-05	CbGpPWpGaD
Lansoprazole—CYP3A4—Metabolism—CYP1A1—chronic obstructive pulmonary disease	3.09e-06	3.46e-05	CbGpPWpGaD
Lansoprazole—CYP2D6—Metabolism—NOS3—chronic obstructive pulmonary disease	3.07e-06	3.44e-05	CbGpPWpGaD
Lansoprazole—CYP2C9—Metabolism—NOS3—chronic obstructive pulmonary disease	3.04e-06	3.41e-05	CbGpPWpGaD
Lansoprazole—CYP1A2—Metabolism—ALB—chronic obstructive pulmonary disease	2.72e-06	3.05e-05	CbGpPWpGaD
Lansoprazole—CYP1A2—Metabolism—NOS3—chronic obstructive pulmonary disease	2.6e-06	2.92e-05	CbGpPWpGaD
Lansoprazole—CYP3A4—Metabolism—ALB—chronic obstructive pulmonary disease	2.1e-06	2.35e-05	CbGpPWpGaD
Lansoprazole—CYP3A4—Metabolism—NOS3—chronic obstructive pulmonary disease	2.01e-06	2.25e-05	CbGpPWpGaD
